» Articles » PMID: 38158514

Prevalence, Reasons for Use, Perceived Benefits, and Awareness of Health Risks of Cannabis Use Among Cancer Survivors - Implications for Policy and Interventions

Overview
Journal J Cancer Surviv
Specialty Oncology
Date 2023 Dec 29
PMID 38158514
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is increasing discourse on the use of cannabis as a palliative for cancer/cancer-treatment-related symptoms. We described the prevalent reasons for use, perceived benefits, and awareness of health risks from cannabis use for cancer management among cancer survivors.

Methods: Cross-sectional survey of adult (≥ 18 years) cancer survivors from 41 US states receiving treatment at a comprehensive cancer center.

Results: Of 1,886 cancer survivors included, 17.4% were current users, 30.5% were former users, and 52.2% were never users of cannabis. Among survivors who currently or formerly used cannabis after their cancer diagnosis (n = 510), the reasons for cannabis use in cancer management were; sleep disturbance (60%), pain (51%), stress (44%), nausea (34%), and mood disorder/depression (32%). Also, about a fifth (91/510) of survivors used cannabis to treat their cancer. Across the different symptoms assessed, over half of the survivors who reported a reason for using cannabis currently or after their cancer diagnosis perceived that cannabis was helpful to a great extent in improving their symptoms. However, of the 167 survivors who reported awareness of potential health risks from cannabis use, the awareness of adverse health risks associated with cannabis use was low: suicidal thoughts (5%), intense nausea and vomiting (6%), depression (11%), anxiety (14%), breathing problems (31%), and interaction with cancer drugs (35%).

Conclusion: Prevalence of cannabis use among survivors was notable, with most reporting a great degree of symptomatic improvement for the specified reason for use. However, only a few were aware of the health risks of cannabis use during cancer management.

Implications For Cancer Survivors: With more cancer survivors using cannabis as a palliative in managing their cancer-related symptoms, future guidelines and policies on cannabis use in cancer management should incorporate cannabis-based interventions to minimize the inadvertent harm from cannabis use during cancer treatment among survivors.

Citing Articles

Awareness and interest in cannabis use for cancer management among cancer survivors.

Osaghae I, Talluri R, Chido-Amajuoyi O, Tanco K, Shah D, Pande M Cancer Med. 2024; 13(1):e6902.

PMID: 38180296 PMC: 10807618. DOI: 10.1002/cam4.6902.


Cannabis Use among Cancer Survivors: Use Pattern, Product Type, and Timing of Use.

Osaghae I, Chido-Amajuoyi O, Khalifa B, Talluri R, Shete S Cancers (Basel). 2023; 15(24).

PMID: 38136367 PMC: 10741826. DOI: 10.3390/cancers15245822.

References
1.
Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

2.
Zhang H, Xie M, Levin M, Archibald S, Jackson B, Young J . Survival outcomes of marijuana users in p16 positive oropharynx cancer patients. J Otolaryngol Head Neck Surg. 2019; 48(1):43. PMC: 6720071. DOI: 10.1186/s40463-019-0365-4. View

3.
Lopez-Pelayo H, Batalla A, Balcells M, Colom J, Gual A . Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments. Psychol Med. 2014; 45(6):1121-33. DOI: 10.1017/S0033291714002463. View

4.
Hall W, Solowij N . Adverse effects of cannabis. Lancet. 1998; 352(9140):1611-6. DOI: 10.1016/S0140-6736(98)05021-1. View

5.
Wilkie G, Sakr B, Rizack T . Medical Marijuana Use in Oncology: A Review. JAMA Oncol. 2016; 2(5):670-675. DOI: 10.1001/jamaoncol.2016.0155. View